Adar1 Capital Management, LLC Vigil Neuroscience, Inc. Transaction History
Adar1 Capital Management, LLC
- $500 Billion
- Q4 2024
A detailed history of Adar1 Capital Management, LLC transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 15,543 shares of VIGL stock, worth $35,127. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,543
Previous 21,737
28.5%
Holding current value
$35,127
Previous $73.9 Million
64.25%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding VIGL
# of Institutions
53Shares Held
26.9MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$13.2 Million1.62% of portfolio
-
Northpond Ventures, LLC4.21MShares$9.52 Million51.65% of portfolio
-
Siren, L.L.C. New York, NY1.99MShares$4.5 Million0.15% of portfolio
-
Bvf Inc San Francisco, CA1.81MShares$4.1 Million0.11% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.51MShares$3.41 Million0.0% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $63.9M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...